Tuberculosis primarily affects the lungs, making pulmonary tuberculosis the most common form of this infectious disease. When someone inhales droplets containing Mycobacterium tuberculosis, the bacteria settle in the alveoli, the tiny air sacs where gas exchange occurs. From this initial landing site, the bacteria can multiply and trigger an inflammatory response as the immune system attempts to contain the infection.
How Tuberculosis Invades Lung Tissue
The journey of tuberculosis affecting lungs begins when a person with active pulmonary TB coughs, sneezes, or speaks, releasing infectious droplets into the air. These droplets, containing thousands of mycobacteria, can remain suspended in the air for several hours. A susceptible individual inhales these particles, allowing the bacteria to bypass the body's initial defenses and reach the delicate lung tissue. Once inside the alveoli, the bacteria are engulfed by immune cells called macrophages, but they have evolved mechanisms to survive and replicate within these very cells.
Initial Immune Response and Containment
After tuberculosis affects lungs, the immune system does not sit idle. Macrophages attempt to destroy the invading bacteria, but M. tuberculosis can resist these efforts. This triggers a complex immune response where more macrophages and other immune cells, such as T-cells, rush to the site of infection. These cells wall off the bacteria, forming small structures known as granulomas. These granulomas are essentially fortified capsules that isolate the bacteria, preventing their spread and often resulting in no symptoms during a latent infection phase.
Progression to Active Pulmonary Tuberculosis
For reasons that are not fully understood, the granulomas can break down in some individuals, allowing the dormant bacteria to become active again. When tuberculosis affects lungs in its active form, the bacteria begin to multiply rapidly, destroying lung tissue in the process. This destruction leads to the classic symptoms of the disease, including a persistent cough that lasts for weeks, coughing up blood or sputum, and severe chest pain that worsens with breathing or coughing.
Symptoms and Diagnostic Challenges
Persistent cough lasting more than three weeks
Chest pain and difficulty breathing
Coughing up blood or rust-colored sputum
Unexplained weight loss and night sweats
Chronic fatigue and loss of appetite
Fever and chills, particularly in the evening
These symptoms often develop gradually and can be mistaken for other respiratory illnesses, which delays diagnosis. Because tuberculosis affects lungs in a way that mimics pneumonia or bronchitis, healthcare providers must maintain a high index of suspicion, especially in individuals with risk factors such as recent exposure, immunosuppression, or travel to endemic areas.
Transmission Dynamics and Public Health Impact
Understanding how tuberculosis affects lungs is crucial for controlling its spread. An individual with active pulmonary TB is contagious and can infect approximately 10-15 people per year through close, prolonged contact. The bacteria are expelled into the air in droplet nuclei, which can linger in poorly ventilated spaces. This airborne transmission is the primary reason why outbreaks occur in crowded environments like prisons, homeless shelters, and healthcare facilities. Effective treatment significantly reduces contagiousness, usually within a few weeks of starting appropriate therapy.
Global Burden and Vulnerable Populations
Tuberculosis remains a leading cause of infectious disease death worldwide, disproportionately affecting populations with limited access to healthcare. Factors that increase the risk of developing active disease after infection include HIV infection, diabetes, malnutrition, and tobacco use. When tuberculosis affects lungs in individuals with compromised immune systems, such as those living with HIV, the disease progresses much more rapidly and is often more severe, highlighting the intersection of infectious disease and social determinants of health.
